Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Leap Therapeutics Inc

(NASDAQ: LPTX)
Add to Portfolio
+0.15 (+6.98%)
as of Feb 18, 2020

Last 2.30
Change +0.15 (+6.98%)
Open 2.17
Prev. Close 2.15
Today's Range
2.17
2.38
52wk Range
0.57
2.97
Volume 784,500
Avg Volume 684,450
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
LPTX +6.98% +187.50% +39.39%
DJIA -0.56% +5.72% +12.94%
S&P 500 -0.29% +8.27% +21.43%

Key Statistics

Annual EPS -1.07
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 48,630
Weighted Alpha +153.60
Standard Deviation +1.21
Profit Margin N/A
Beta 2.24

Growth Rates

YTD +105.36%
1-Year +40.24%
3-Year -67.47%

Opinion

Sell Hold Buy

Recent Headlines

Leap Therapeutics to Present at 22nd Annual BIO CEO &

PR Newswire via COMTEX - Tue Feb 04, 07:00AM EST
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief Financial Officer, will present a corporate overview at t(full story)
LPTX: 2.30 (+0.15)

Leap Therapeutics Presents Updated Data at the ASCO

PR Newswire via COMTEX - Thu Jan 23, 07:00AM EST
Leap Therapeutics, Inc. (Nasdaq: LPTX) today presented updated clinical data from its recently completed Phase 1/2 clinical trial of DKN-01 in patients with advanced or recurrent esophagogastric cancer (EGC) at the 2020 ASCO GI an(full story)
LPTX: 2.30 (+0.15)

Biotechnological Breakthroughs Help Revamp the Fight

PR Newswire via COMTEX - Thu Jan 09, 09:22AM EST
Biotechnology plays an important role throughout various sectors by improving industry standards, services, and developing new products. While agriculture, material science and environmental science are major areas of research, th(full story)
TOMDF: 0.0350 (-0.0050), AGEN: 3.90 (+0.24), LPTX: 2.30 (+0.15), TRIL: 3.68 (+0.24), VSTM: 2.06 (+0.06)

Leap Therapeutics Announces Closing of Previously

PR Newswire via COMTEX - Tue Jan 07, 04:05PM EST
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of its previously announced equity financing to issue 1,421,801 shares of(full story)
LPTX: 2.30 (+0.15)

Leap Therapeutics and BeiGene Announce Exclusive

PR Newswire via COMTEX - Fri Jan 03, 08:54AM EST
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted immuno-oncology therapeutics, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing an(full story)
BGNE: 170.79 (-0.30), LPTX: 2.30 (+0.15)